These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Headache and cortisol responses to m-chlorophenylpiperazine are highly correlated. Gordon ML; Lipton RB; Brown SL; Nakraseive C; Russell M; Pollack SZ; Korn ML; Merriam A; Solomon S; van Praag HM Cephalalgia; 1993 Dec; 13(6):400-5. PubMed ID: 8313453 [TBL] [Abstract][Full Text] [Related]
46. Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects. Broocks A; Meyer T; Gleiter CH; Hillmer-Vogel U; George A; Bartmann U; Bandelow B Psychopharmacology (Berl); 2001 May; 155(3):234-41. PubMed ID: 11432685 [TBL] [Abstract][Full Text] [Related]
47. Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse. Moss HB; Yao JK; Panzak GL Biol Psychiatry; 1990 Aug; 28(4):325-38. PubMed ID: 2397249 [TBL] [Abstract][Full Text] [Related]
48. Brain slow potentials (CNV), prolactin, and schizophrenia. Rizzo PA; Albani GF; Spadaro M; Morocutti C Biol Psychiatry; 1983 Feb; 18(2):175-83. PubMed ID: 6131702 [TBL] [Abstract][Full Text] [Related]
49. A new postsynaptic serotonin receptor agonist suitable for studies in humans. Mueller EA; Murphy DL; Sunderland T; Jones J Psychopharmacol Bull; 1985; 21(3):701-4. PubMed ID: 2994164 [No Abstract] [Full Text] [Related]
50. Effect of clozapine on d-fenfluramine-evoked neuroendocrine responses in schizophrenia and its relationship to clinical improvement. Curtis VA; Wright P; Reveley A; Kerwin R; Lucey JV Br J Psychiatry; 1995 May; 166(5):642-6. PubMed ID: 7620750 [TBL] [Abstract][Full Text] [Related]
51. Platelet serotonin-2 receptors in schizophrenia: effects of illness and neuroleptic treatment. Pandey SC; Sharma RP; Janicak PG; Marks RC; Davis JM; Pandey GN Psychiatry Res; 1993 Jul; 48(1):57-68. PubMed ID: 8105499 [TBL] [Abstract][Full Text] [Related]
52. Relationship between serum cholesterol levels and meta-chlorophenylpiperazine-induced cortisol responses in healthy men and women. Terao T; Nakamura J; Yoshimura R; Ohmori O; Takahashi N; Kojima H; Soeda S; Shinkai T; Nakano H; Okuno T Psychiatry Res; 2000 Oct; 96(2):167-73. PubMed ID: 11063789 [TBL] [Abstract][Full Text] [Related]
53. Blunted oral body temperature response to MK-212 in cocaine addicts. Lee MA; Meltzer HY Drug Alcohol Depend; 1994 Jun; 35(3):217-22. PubMed ID: 7956751 [TBL] [Abstract][Full Text] [Related]
54. Serotonergic function in social phobia: comparison to normal control and obsessive-compulsive disorder subjects. Hollander E; Kwon J; Weiller F; Cohen L; Stein DJ; DeCaria C; Liebowitz M; Simeon D Psychiatry Res; 1998 Jul; 79(3):213-7. PubMed ID: 9704868 [TBL] [Abstract][Full Text] [Related]
55. 5-HT(1A) receptor dysfunction in female patients with schizophrenia. Lee MA; Meltzer HY Biol Psychiatry; 2001 Nov; 50(10):758-66. PubMed ID: 11720694 [TBL] [Abstract][Full Text] [Related]
56. Serotonergic function and negative and depressive symptomatology in schizophrenia and major depression. Abel KM; O'Keane V; Murray RM; Cleare AJ Psychoneuroendocrinology; 1997 Oct; 22(7):539-48. PubMed ID: 9373887 [TBL] [Abstract][Full Text] [Related]
57. Central serotonergic function in patients with predominantly negative symptoms of schizophrenia. Uhl I; Kulik A; Roser P; Theodoridou A; Wyss C; Norra C; Brüne M; Kawohl W; Juckel G Schizophr Res; 2018 Mar; 193():443-444. PubMed ID: 28641887 [No Abstract] [Full Text] [Related]
58. Serotonergic function in panic disorder: endocrine responses to D-fenfluramine. Judd FK; Apostolopoulos M; Burrows GD; Norman TR Prog Neuropsychopharmacol Biol Psychiatry; 1994 Mar; 18(2):329-37. PubMed ID: 8208982 [TBL] [Abstract][Full Text] [Related]